Key facts
- This page summarizes James Dara's Form 4 filing for Nano-X Imaging Ltd. (NNOX).
- 1 reported transaction and 4 derivative rows are listed below.
- Accepted by SEC: 13 Oct 2026, 09:12.
James Dara - 11 Oct 2026 Form 4 Insider Report for Nano-X Imaging Ltd. (NNOX)
- Reporting relationship
- GM Source & Services Division
- Issuer ticker
- NNOX
- Reported as of
- 11 Oct 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Oct 2026, 09:12:13 UTC
- Prior SEC filing
- 18 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marina Gofman Feler, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
James Dara filed Form 4 for Nano-X Imaging Ltd. (NNOX) on 13 Oct 2026.
Change
- Previous filing in this sequence was filed on 18 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002049065
Primary reporting owner
Dara James
- Relationship
- GM Source & Services Division
- Address
- C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA
- Signature
- /s/ Marina Gofman Feler, attorney-in-fact
- Signature date
- 13 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NNOX
transaction
Ordinary Shares
Award
- Transaction value
- Shares
- +28,283
- Change %
- Price
- $0.000000*
- Shares after
- 28,283
- Date
- 11 Oct 2026
- Ownership
- Direct
- Footnotes
- F1, F2
NNOX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 39,474
- Date
- 11 Oct 2026
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100,000
- Date
- 11 Oct 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 100,000
- Exercise price
- $49.68
- Footnotes
- F3, F5
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 11 Oct 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 25,000
- Exercise price
- $17.63
- Footnotes
- F3, F6
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 11 Oct 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 10,000
- Exercise price
- $17.63
- Footnotes
- F3, F7
NNOX
holding
Derivative
Stock Option (right to buy ordinary shares)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 55,000
- Date
- 11 Oct 2026
- Ownership
- Direct
- Underlying class
- Ordinary shares
- Underlying amount
- 55,000
- Exercise price
- $11.52
- Footnotes
- F3, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.
Footnote F2
The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028-- subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.
Footnote F3
There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
Footnote F4
The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).
Footnote F5
The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.
Footnote F6
The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.
Footnote F7
The options reported in this row were granted to the Reporting Person by the Issuer on August 11, 2022 and are fully vested and exercisable as of the date of this report.
Footnote F8
The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
SEC remarks
Exhibit 24.1 - Power of Attorney